Scryb Inc
CNSX:SCYB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (10.5), the stock would be worth CA$0.05 (56% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 24 | CA$0.12 |
0%
|
| 3-Year Average | 10.5 | CA$0.05 |
-56%
|
| 5-Year Average | 17.6 | CA$0.09 |
-26%
|
| Industry Average | 1.9 | CA$0.01 |
-92%
|
| Country Average | 2.9 | CA$0.01 |
-88%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
S
|
Scryb Inc
CNSX:SCYB
|
5.6m CAD | 24 | -2.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 16.1 | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 3.5 | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 4.8 | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 2.9 | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 4.1 | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 7.7 | 44.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 1.7 | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 10.4 | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 1.9 | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 5.8 | 21 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.4 |
| Median | 2.9 |
| 70th Percentile | 4.9 |
| Max | 15 623 917.6 |
Other Multiples
Scryb Inc
Glance View
Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company is headquartered in Etobicoke, Ontario. The Company’s platform offers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform adopts across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The Company’s cloud-based platform is composed of elements including sensor technology, Internet of things (IoT), predictive analytics, and computer vision. Its portfolio includes Pharmatrac, Fionet, Handheld Diagnostics and Cybeats. Pharmatrac is an artificial intelligence (AI) digital health company that provides insight into medication behavior. Fionet is a data-and-device platform that enables controlled testing and tracking for pandemic response. Handheld Diagnostics brings lab-quality analysis to bedside in critical care situations. Cybeats builds certainty in software security.
